Drugs / rhu-pGelsolin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1/2 | NCT00671307 | Mar 2008 → Mar 2010 | brain injury, infectious disease | Critical Biologics Corporation | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | rhu-pGelsolin | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00671307 ↗ |
| Modality | Protein / enzyme biologic | “IV formulation of recombinant plasma gelsolin” NCT00671307 ↗ |
| Route | Intravenous | “given as an IV infusion over 1 hour” NCT00671307 ↗ |